PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection

Permanent URI for this collectionhttps://hdl.handle.net/11147/7645

Browse

Now showing 1 - 5 of 5

Electrochemical Sensors for Rapid Cardiovascular Disease Diagnostics
(Amer Chemical Soc, 2025) Sanko, Vildan; Tekin, H. Cumhur
Cardiovascular diseases (CVDs) remain a leading cause of death, particularly in developing countries, where their incidence continues to rise. Traditional CVD diagnostic methods are often time-consuming and inconvenient, necessitating more efficient alternatives. Rapid and accurate measurement of cardiac biomarkers released into body fluids is critical for early detection, timely intervention, and improved patient outcomes. Electrochemical methods offer a robust solution by enabling rapid, sensitive, selective, and multiplex detection of CVD biomarkers, paving the way for early diagnosis and treatment advancements. This review highlights the performance and potential of electrochemical sensors for detecting specific CVD biomarkers and related organic molecules. It explores electrochemical sensing mechanisms, their evolution, the integration of nanotechnology, and diverse sensing platforms. It also examines emerging technologies such as microfluidic, smartphone-integrated sensors, and microneedle- and tattoo-based sensors. Challenges and opportunities in integrating electrochemical sensors into point-of-care (POC) and wearable devices are discussed. Finally, the review compares commercial CVD sensors with existing methods and outlines future directions to advance the field.
Enabling Fluorescence Lifetime Imaging Multiplexing Using UnaG Through Its Modification With Canonical and Noncanonical Amino Acids
(Amer Chemical Soc, 2025) Terekhova, Valentina V.; Bodunova, Daria V.; Gorokhov, Egor S.; Tsoraev, Georgy V.; Sidorenko, Svetlana V.; Vasilev, Ruslan A.; Kirpichnikov, Mikhail P.
Fluorogen-activating proteins are powerful molecular tools for microscopy, including functional imaging. These proteins serve as an alternative to GFP-like proteins, as they do not require oxygen for chromophore maturation. However, the restricted selectivity of proteins to chromophores, combined with the limited number of spectral channels of conventional fluorescent microscopes, hinders the development of multicolor synthetic dyes. Additionally, the poor cell and tissue permeability of synthetic chromophores further limits their utility. In this work, we address these challenges by combining time-resolved methods with the rational design of the UnaG protein, which utilizes bilirubin as a natural chromophore. To turn UnaG into a palette of probes for fluorescence lifetime imaging microscopy (FLIM), we solved two practical problems: first, we determined the limits of bilirubin lifetime variations in response to changes in the protein structure and, second, we determined what minimal structural changes can be reliably distinguished by lifetime analysis in cellula. Combining classical point mutagenesis and the translational introduction of noncanonical amino acids, we generated UnaG with fluorescence lifetimes ranging from hundreds of picoseconds to nanoseconds. We explored the potential for further modification of the UnaG protein matrix to optimize spectral and temporal characteristics of bilirubin fluorescence and its quantitative detection through time-resolved approaches.
Citation - WoS: 8
Citation - Scopus: 10
Pcr-Free Methodology for Detection of Single-Nucleotide Polymorphism With a Cationic Polythiophene Reporter
(American Chemical Society, 2021) Yücel, Müge; Koç, Altuğ; UÜgenalp, Ayfer; Akkoç, Gün Deniz; Ceyhan, Metin; Yıldız, Ümit Hakan
This study presents a nonamplification-based nucleic acid assay for the detection of single-nucleotide polymorphism (SNP) associated with familial Mediterranean fever (FMF) besides polymerase chain reaction (PCR)-based methodologies. The major objective is to show the potential of the proposed assay for rapid screening of FMF in a Mediterranean region of 400 million population. The assay relies on binding difference of specially designed wild and mutant primers to the target genomic DNA, followed by determination of unbound primers by quick titration of a cationic polythiophene reporter. The fluorescent reporter exhibits signal transition from 525 to 580 nm in the presence of unbound primers, and it correlates the binding affinity of label-free primers to the homozygous wild and mutant genomes. As a proof of concept, 26 real samples are studied relying on the ON and OFF fluorescence signals of the cationic polythiophene reporter. The results are analyzed by principal component analysis (PCA), which provides clear separation of healthy and patient individuals. The further analysis by support vector machine (SVM) classification has revealed that our assay converges to 96% overall accuracy. These results support that the PCR-free nucleic acid assay has a significant potential for rapid and cost-effective screening of familial Mediterranean fever.
Citation - WoS: 2
Citation - Scopus: 2
Plasmonic Functional Assay Platform Determines the Therapeutic Profile of Cancer Cells
(American Chemical Society, 2023) Çetin, Arif E.; Topkaya, Seda Nur; Yazıcı, Ziya Ata; Yalçın Özuysal, Özden
Functional assay platforms could identify the biophysicalpropertiesof cells and their therapeutic response to drug treatments. Despitetheir strong ability to assess cellular pathways, functional assaysrequire large tissue samples, long-term cell culture, and bulk measurements.Even though such a drawback is still valid, these limitations didnot hinder the interest in these platforms for their capacity to revealdrug susceptibility. Some of the limitations could be overcome withsingle-cell functional assays by identifying subpopulations usingsmall sample volumes. Along this direction, in this article, we developeda high-throughput plasmonic functional assay platform to identifythe growth profile of cells and their therapeutic profile under therapiesusing mass and growth rate statistics of individual cells. Our technologycould determine populations' growth profiles using the growthrate data of multiple single cells of the same population. Evaluatingspectral variations based on the plasmonic diffraction field intensityimages in real time, we could simultaneously monitor the mass changefor the cells within the field of view of a camera with the capacityof > & SIM;500 cells/h scanning rate. Our technology could determinethe therapeutic profile of cells under cancer drugs within few hours,while the classical techniques require days to show reduction in viabilitydue to antitumor effects. The platform could reveal the heterogeneitywithin the therapeutic profile of populations and determine subpopulationsshowing resistance to drug therapies. As a proof-of-principle demonstration,we studied the growth profile of MCF-7 cells and their therapeuticbehavior to standard-of-care drugs that have antitumor effects asshown in the literature, including difluoromethylornithine (DFMO),5-fluorouracil (5-FU), paclitaxel (PTX), and doxorubicin (Dox). Wesuccessfully demonstrated the resistant behavior of an MCF-7 variantthat could survive in the presence of DFMO. More importantly, we couldprecisely identify synergic and antagonistic effects of drug combinationsbased on the order of use in cancer therapy. Rapidly assessing thetherapeutic profile of cancer cells, our plasmonic functional assayplatform could be used to reveal personalized drug therapies for cancerpatients.
Citation - WoS: 11
Citation - Scopus: 14
Utilizing Magnetic Levitation To Detect Lung Cancer-Associated Exosomes
(Amer Chemical Soc, 2024) Sozmen, Alper Baran; Arslan-Yildiz, Ahu
Extracellular vesicles, especially exosomes, have attracted attention in the last few decades as novel cancer biomarkers. Exosomal membrane proteins provide easy-to-reach targets and can be utilized as information sources of their parent cells. In this study, a MagLev-based, highly sensitive, and versatile biosensor platform for detecting minor differences in the density of suspended objects is proposed for exosome detection. The developed platform utilizes antibody-functionalized microspheres to capture exosomal membrane proteins (ExoMPs) EpCAM, CD81, and CD151 as markers for cancerous exosomes, exosomes, and non-small cell lung cancer (NSCLC)-derived exosomes, respectively. Initially, the platform was utilized for protein detection and quantification by targeting solubilized ExoMPs, and a dynamic range of 1-100 nM, with LoD values of 1.324, 0.638, and 0.722 nM for EpCAM, CD81, and CD151, were observed, respectively. Then, the sensor platform was tested using exosome isolates derived from NSCLC cell line A549 and MRC5 healthy lung fibroblast cell line. It was shown that the sensor platform is able to detect and differentiate exosomal biomarkers derived from cancerous and non-cancerous cell lines. Overall, this innovative, simple, and rapid method shows great potential for the early diagnosis of lung cancer through exosomal biomarker detection.

Browse

Browsing PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection by Journal "ACS Sensors"